The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
493 jobs Number of planned job losses
Announcement Date
10 July 2008
Employment effect (start)
10 July 2008
Foreseen end date
30 December 2011
Description
Pharmesutical giant GlaxoSmithKline (GSK) has announced the closure of its factory in Crawley with the loss of almost 500 jobs. The job losses will be implemented by the end of 2011. The company has blamed the closure on "declining volumes, regulatory delays and patent expiries". Staff at the site currently manufacture prescription medications including medicines to treat Parkinson's disease, heart disease, HIV/AIDS, bacterial skin infections, depression, and hypertension. Consultation with trade unions at the site are due to start immediately.
Sources
10 July 2008: BBC Website
Citation
Eurofound (2008), Glaxo Smith Kline, Closure in United Kingdom, factsheet number 66836, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/66836.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
